Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Schering AG to transfer oxybutynin incontinence ring to Barr

April 13, 2004

Preference for tadalafil among patients with erectile dysfunction

April 13, 2004

Tamsulosin improves symptoms and quality of life in patients with CP/CPPS

April 13, 2004

Vardenafil improves erection and depression in patients with erectile dysfunction

April 8, 2004

Novel ALK5 inhibitors prepared and tested by GSK team

April 6, 2004

Alfuzosin reduces need for surgery in acute urinary retention

April 2, 2004

Beta adrenergic receptor targeted for treatment of male sexual dysfunction

April 2, 2004

Studies find dutasteride effective in benign prostatic hyperplasia

April 1, 2004

RO-3202904 may be better tolerated than other overactive bladder treatments

April 1, 2004

New data on tamsulosin presented at the 19th EAU congress

April 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...